Preparing for the EU’s new HTA regulation and Joint Clinical Assessment process

Veeva’s Richard Young looks back on breakthroughs in clinical trial technology and why the industry must continue to make trials more patient centric.

Sending out instrumentation to trade shows or customer locations for demonstration purposes is expensive and not risk free. Enter 3D virtual worlds.

How Astrea Bioseparations is expanding its expertise into the advanced medicines space.

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Biopharma tech continues to advance so why is downstream processing such a headache?

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking